285 related articles for article (PubMed ID: 20609088)
1. Review: anticoagulation for haemodialysis.
Suranyi M; Chow JS
Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
4. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
5. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
6. [Heparin-induced thrombocytopenia syndrome and thrombosis in patients undergoing periodic haemodialysis].
Gregorini G; Bellandi D; Martini G; Volpi R
G Ital Nefrol; 2002; 19(6):672-92. PubMed ID: 12508172
[TBL] [Abstract][Full Text] [Related]
7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for continuous renal replacement therapy.
Tolwani AJ; Wille KM
Semin Dial; 2009; 22(2):141-5. PubMed ID: 19426417
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
Charif R; Davenport A
Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in continuous renal replacement therapy.
Hidalgo N; Hynes-Gay P; Hill S; Burry L
Dynamics; 2001; 12(4):13-7. PubMed ID: 11845482
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin.
Borawski J
Am J Kidney Dis; 2006 Jan; 47(1):37-41. PubMed ID: 16377383
[TBL] [Abstract][Full Text] [Related]
15. [Management of heparin-induced thrombocytopenia].
Aouizerate P; Guizard M
Therapie; 2002; 57(6):577-88. PubMed ID: 12666266
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
Andrassy K
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328
[TBL] [Abstract][Full Text] [Related]
17. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
Menajovsky LB
Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia--a big deal? It should be!
Jamani N; Ouwendyk M
CANNT J; 2000; 10(2):30-5, 39-44; quiz 36-8. PubMed ID: 15712466
[TBL] [Abstract][Full Text] [Related]
20. New parenteral anticoagulants in development.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Rocha E; Pozo-Hernández C; Vargas-Castrillón E
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):33-59. PubMed ID: 21045018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
